Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buscopan for Prolonged Labor in Nulliparous Women
NCT03430362Completed
- Sponsor
- Cairo University
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of hyoscine butylbromide in prolonged labor (2 arms), sponsored by Cairo University. Primary endpoint: Duration of active phase of first stage of labor at 8 hours. Started Mar 2018; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
prolonged labor
Beyond the preview
Go deeper on NCT03430362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430362.